The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Matrix metalloproteinases (MMPs): Chemical–biological functions and (Q)SARs
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Golbraikh, A., & Tropsha, A. (2002) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(01)00123-1 · Cited by 3,735
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Tropsha, A., Gramatica, P., & Gombar, V. K. (2003) · QSAR & Combinatorial Science · doi:10.1002/qsar.200390007 · Cited by 2,188
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Eriksson, L., Jaworska, J., Worth, A. P., Cronin, M. T. D., McDowell, R. M., & Gramatica, P. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.5758 · Cited by 1,325
Frisch, S. M., & Screaton, R. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00251-9 · Cited by 1,249
Matrix metalloproteinases: a tail of a frog that became a prince
Brinckerhoff, C. E., & Matrisian, L. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm763 · Cited by 1,105
HANSCH, C., MALONEY, P. P., FUJITA, T., & MUIR, R. M. (1962) · Nature · doi:10.1038/194178b0 · Cited by 1,056
Self-citationDesign and Therapeutic Application of Matrix Metalloproteinase Inhibitors
Whittaker, M., Floyd, C. D., Brown, P., & Gearing, A. J. H. (1999) · Chemical Reviews · doi:10.1021/cr9804543 · Cited by 982
Molecular Recognition of Protein−Ligand Complexes: Applications to Drug Design
Babine, R. E., & Bender, S. L. (1997) · Chemical Reviews · doi:10.1021/cr960370z · Cited by 892
The use of characteristic volumes to measure cavity terms in reversed phase liquid chromatography
Abraham, M. H., & McGowan, J. C. (1987) · Chromatographia · doi:10.1007/bf02311772 · Cited by 858
Cramer, R. D., Bunce, J. D., Patterson, D. E., & Frank, I. E. (1988) · Quantitative Structure-Activity Relationships · doi:10.1002/qsar.19880070105 · Cited by 833
Interleukin-1, Interleukin-1 Receptors and Interleukin-1 Receptor Antagonist
Dinarello, C. A. (1998) · International Reviews of Immunology · doi:10.3109/08830189809043005 · Cited by 761
Scaling down imaging: molecular mapping of cancer in mice
Weissleder, R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc701 · Cited by 708
Structure of Human Pro-Matrix Metalloproteinase-2: Activation Mechanism Revealed
Morgunova, E., Tuuttila, A., Bergmann, U., Isupov, M., Lindqvist, Y., Schneider, G., & Tryggvason, K. (1999) · Science · doi:10.1126/science.284.5420.1667 · Cited by 540
Yu, W.-H., Woessner, J. F., McNeish, J. D., & Stamenkovic, I. (2002) · Genes & Development · doi:10.1101/gad.925702 · Cited by 471
Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator
Wang, X., Lee, S.-R., Arai, K., Lee, S.-R., Tsuji, K., Rebeck, G. W., & Lo, E. H. (2003) · Nature Medicine · doi:10.1038/nm926 · Cited by 460
Powell, W. C., Fingleton, B., Wilson, C. L., Boothby, M., & Matrisian, L. M. (1999) · Current Biology · doi:10.1016/s0960-9822(00)80113-x · Cited by 424
Sympson, C. J. (1994) · The Journal of Cell Biology · doi:10.1083/jcb.125.3.681 · Cited by 400
Matrix metalloproteinases in tumor–host cell communication
Lynch, C. C., & Matrisian, L. M. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700909.x · Cited by 386
Mitsiades, N., Yu, W., Poulaki, V., Tsokos, M., & Stamenkovic, I. (2001) · PubMed · Cited by 365
Bode, W., Reinemer, P., Huber, R., Kleine, T., Schnierer, S., & Tschesche, H. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06378.x · Cited by 339
Structure of the Catalytic Domain of Fibroblast Collagenase Complexed with an Inhibitor
Lovejoy, B., Cleasby, A., Hassell, A. M., Longley, K., Luther, M. A., Weigl, D., McGeehan, G., McElroy, A. B., Drewry, D., Lambert, M. H., et al. (1994) · Science · doi:10.1126/science.8278810 · Cited by 328
MacPherson, L. J., Bayburt, E. K., Capparelli, M. P., Carroll, B. J., Goldstein, R., Justice, M. R., Zhu, L., Hu, S.-I., Melton, R. A., Fryer, L., et al. (1997) · Journal of Medicinal Chemistry · doi:10.1021/jm960871c · Cited by 326
Li, J., Brick, P., O'Hare, M., Skarzynski, T., Lloyd, L., Curry, V., Clark, I., Bigg, H., Hazleman, B., Cawston, T., et al. (1995) · Structure · doi:10.1016/s0969-2126(01)00188-5 · Cited by 261
Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage.
Wu, J. J., Lark, M. W., Chun, L. E., & Eyre, D. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)67640-4 · Cited by 259
Nagase, H., Fields, C. G., & Fields, G. B. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31914-2 · Cited by 249
The contradictions of the insulin-like growth factor 1 receptor
Baserga, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203854 · Cited by 234
Structural Basis for the Highly Selective Inhibition of MMP-13
Engel, C. K., Pirard, B., Schimanski, S., Kirsch, R., Habermann, J., Klingler, O., Schlotte, V., Weithmann, K. U., & Wendt, K. U. (2005) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.11.014 · Cited by 228
Scozzafava, A., & Supuran, C. T. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000027t · Cited by 225
Chem-Bioinformatics: Comparative QSAR at the Interface between Chemistry and Biology
Hansch, C., Hoekman, D., Leo, A., Weininger, D., & Selassie, C. D. (2002) · Chemical Reviews · doi:10.1021/cr0102009 · Cited by 218
Self-citationPogliani, L. (2000) · Chemical Reviews · doi:10.1021/cr0004456 · Cited by 203
Structure of the catalytic domain of human fibroblast collagenase complexed with an inhibitor
Borkakoti, N., Winkler, F. K., Williams, D. H., D'Arcy, A., Broadhurst, M. J., Brown, R. A., Johnson, W. H., & Murray, E. J. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb0294-106 · Cited by 197
1.56 Å structure of mature truncated human fibroblast collagenase
Spurlino, J. C., Smallwood, A. M., Carlton, D. D., Banks, T. M., Vavra, K. J., Johnson, J. S., Cook, E. R., Falvo, J., Wahl, R. C., Pulvino, T. A., et al. (1994) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.340190203 · Cited by 184
Grams, F., Reinemer, P., Powers, J. C., Kleine, T., Pieper, M., Tschesche, H., Huber, R., & Bode, W. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.0830m.x · Cited by 180
Netzel-Arnett, S., Sang, Q. X., Moore, W. G. I., Navre, M., Birkedal-Hansen, H., & Van Wart, H. E. (1993) · Biochemistry · doi:10.1021/bi00076a016 · Cited by 173
Matrix Metalloproteinase Inhibitors as Anticancer Therapeutics
Mannello, F., Tonti, G. A., & Papa, S. (2005) · Current Cancer Drug Targets · doi:10.2174/1568009054064615 · Cited by 163
Smith, M. M., Shi, L., & Navre, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.12.6440 · Cited by 162
Structure of human neutrophil collagenase reveals large S1′ specificity pocket
Stams, T., Spurlino, J. C., Smith, D. L., Wahl, R. C., Ho, T. F., Qoronfleh, M. W., Banks, T. M., & Rubin, B. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb0294-119 · Cited by 161
Crystal Structures of Recombinant 19-kDa Human Fibroblast Collagenase Complexed to Itself
Lovejoy, B., Hassell, A. M., Luther, M., Weigl, D., & Jordan, S. R. (1994) · Biochemistry · doi:10.1021/bi00193a006 · Cited by 156
The NMR structure of the inhibited catalytic domain of human stromelysin–1
Gooley, P. R., O’Connell, J. F., Marcy, A. I., Cuca, G. C., Salowe, S. P., Bush, B. L., Hermes, J. D., Esser, C. K., Hagmann, W. K., Springer, J. P., et al. (1994) · Nature Structural & Molecular Biology · doi:10.1038/nsb0294-111 · Cited by 154
MMP-9 deficiency affects axonal outgrowth, migration, and apoptosis in the developing cerebellum
Vaillant, C., Meissirel, C., Mutin, M., Belin, M.-F., Lund, L. R., & Thomasset, N. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00196-9 · Cited by 150
Multiple roles of matrix metalloproteinases during apoptosis
Mannello, F., Luchetti, F., Falcieri, E., & Papa, S. (2005) · APOPTOSIS · doi:10.1007/s10495-005-6058-7 · Cited by 147
The promise and peril of surrogate end points in cancer research
Schatzkin, A. G., & Gail, M. H. (2002) · Nature reviews. Cancer · doi:10.1038/nrc702 · Cited by 145
Chintala, S. K., Zhang, X., Austin, J. S., & Fini, M. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m204824200 · Cited by 136
Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells
Strand, S., Vollmer, P., van den Abeelen, L., Gottfried, D., Alla, V., Heid, H., Kuball, J. H. E., Theobald, M., Galle, P. R., & Strand, D. J. (2004) · Oncogene · doi:10.1038/sj.onc.1207387 · Cited by 134
Lee, S.-R., & Lo, E. H. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000122747.72175.47 · Cited by 128
Boulay, A., Masson, R., Chenard, M., Fahime, E. E., Cassard, L., Bellocq, J., Sautès‐Fridman, C., Basset, P., & Rio, M. C. (2001) · PubMed · Cited by 127
Seltzer, J. L., Akers, K. T., Weingarten, H. I., Grant, G. A., McCourt, D. W., & Eisen, A. Z. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)30519-7 · Cited by 125
Sawa, M., Kiyoi, T., Kurokawa, K., Kumihara, H., Yamamoto, M., Miyasaka, T., Ito, Y., Hirayama, R., Inoue, T. M., Kirii, Y., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm0103211 · Cited by 118
Cuniasse, P., Devel, L., Makaritis, A., Beau, F., Georgiadis, D., Matziari, M., Yiotakis, A., & Dive, V. (2004) · Biochimie · doi:10.1016/j.biochi.2004.09.025 · Cited by 117
Witty, J. P., Lempka, T., Coffey, R. J., & Matrisian, L. M. (1995) · PubMed · Cited by 117
On the role of polarizability in QSAR
Verma, R. P., Kurup, A., & Hansch, C. H. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.039 · Cited by 116
Self-citationIshizuya‐Oka, A., Li, Q., Amano, T., Damjanovski, S., Ueda, S., & Shi, Y. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.150.5.1177 · Cited by 116
Vassiliou, S., Mucha, A., Cuniasse, P., Georgiadis, D., Lucet-Levannier, K., Beau, F., Kannan, R., Murphy, G., Knäuper, V., Rio, M., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9900164 · Cited by 114
A helping hand for collagenases: the haemopexin-like domain
Bode, W. (1995) · Structure · doi:10.1016/s0969-2126(01)00185-x · Cited by 110
Signalling mechanisms of anoikis.
Zhan, M., Zhao, H., & Han, Z. (2004) · PubMed · doi:10.14670/hh-19.973 · Cited by 109
Matrix Metalloproteinase Inhibitors: A Review on Pharmacophore Mapping and (Q)Sars Results
Kontogiorgis, C. A., Papaioannou, P., & Hadjipavlou‐Litina, D. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053363243 · Cited by 102
Yamamoto, M., Tsujishita, H., Hori, N., Ohishi, Y., Inoue, S., Ikeda, S., & Okada, Y. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm970404a · Cited by 101
Selassie, C. D., Kapur, S., Verma, R. P., & del Rosario, M. C. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050567w · Cited by 100
Self-citationO'Brien, P. M., Ortwine, D. F., Pavlovsky, A. G., Picard, J. A., Sliskovic, D. R., Roth, B. D., Dyer, R. D., Johnson, L. L., Man, C.-F., & Hallak, H. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9903141 · Cited by 99
Terp, G. E., Johansen, B. N., Christensen, I. T., & Jørgensen, F. S. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm001090l · Cited by 97
Kiyama, R., Tamura, Y., Watanabe, F., Tsuzuki, H., Ohtani, M., & Yodo, M. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm980514x · Cited by 97
Structure-based design of potent and selective inhibitors of collagenase-3 (MMP-13)
Kim, S., Pudzianowski, A. T., Leavitt, K. J., Barbosa, J., McDonnell, P. A., Metzler, W. J., Rankin, B. M., Liu, R., Vaccaro, W. D., & Pitts, W. J. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2004.12.016 · Cited by 96
On the Role of Polarizability in Chemical−Biological Interactions
Hansch, C. H., Steinmetz, W. E., Leo, A. J., Mekapati, S. B., Kurup, A., & Hoekman, D. (2002) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci020378b · Cited by 95
Self-citationComparative QSAR and the Radical Toxicity of Various Functional Groups
Selassie, C. D., Garg, R., Kapur, S., Kurup, A., Verma, R. P., Mekapati, S. B., & Hansch, C. H. (2002) · Chemical Reviews · doi:10.1021/cr940024m · Cited by 90
Self-citationSchröder, J., Henke, A., Wenzel, H., Brandstetter, H., Stammler, H., Stammler, A., Pfeiffer, W. ‐., & Tschesche, H. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010887p · Cited by 88
Natural Bio-Drugs as Matrix Metalloproteinase Inhibitors: New Perspectives on the Horizon?
Mannello, F. (2006) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489206775246421 · Cited by 88
Pikul, S., Dunham, K. M., Almstead, N. G., De, B., Natchus, M. G., Anastasio, M. V., McPhail, S. J., Snider, C. E., Taiwo, Y. O., Chen, L., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980142s · Cited by 87
An approach toward the problem of outliers in QSAR
Verma, R. P., & Hansch, C. H. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.05.002 · Cited by 80
Self-citationQuest for Selectivity in Inhibition of Matrix Metalloproteinases
Brown, S., Meroueh, S. O., Fridman, R. A., & Mobashery, S. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043387854 · Cited by 70
Metalloproteinase Shedding of Fas Ligand Regulates β-Amyloid Neurotoxicity
Ethell, D. W., Kinloch, R. A., & Green, D. R. (2002) · Current Biology · doi:10.1016/s0960-9822(02)01140-5 · Cited by 70
Natchus, M. G., Bookland, R. G., De, B., Almstead, N. G., Pikul, S., Janusz, M. J., Heitmeyer, S. A., Hookfin, E. B., Hsieh, L. C., Dowty, M. E., et al. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000246e · Cited by 66
Becker, D. P., Villamil, C. I., Barta, T. E., Bedell, L. J., Boehm, T. L., DeCrescenzo, G. A., Freskos, J. N., Getman, D. P., Hockerman, S. L., Heintz, R., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0500875 · Cited by 66
Aranapakam, V., Grosu, G. T., Davis, J. M., Hu, B., Ellingboe, J. W., Baker, J., Skotnicki, J. S., Zask, A., DiJoseph, J. F., Sung, A., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm0205548 · Cited by 64
Makarova, A., MIKHAILENKO, I. A., Bugge, T. H., List, K., Lawrence, D. A., & Strickland, D. K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309150200 · Cited by 64
Inhibition of matrix metalloproteinases by N-carboxyalkyl peptides
Chapman, K. T., Kopka, I. E., Durette, P. L., Esser, C. K., Lanza, T. J., Izquierdo-Martin, M., Niedzwiecki, L. M., Chang, B. C., & Harrison, R. K. (1993) · Journal of Medicinal Chemistry · doi:10.1021/jm00078a019 · Cited by 64
Stromelysin‐3 suppresses tumor cell apoptosis in a murine model*
Wu, E., Mari, B. P., Wang, F., Anderson, I. C., Sunday, M. E., & Shipp, M. A. (2001) · Journal of Cellular Biochemistry · doi:10.1002/jcb.1181 · Cited by 64
Mucha, A., Cuniasse, P., Kannan, R., Beau, F., Yiotakis, A., Basset, P., & Dive, V. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2763 · Cited by 62
Potent pyrimidinetrione-based inhibitors of MMP-13 with enhanced selectivity over MMP-14
Blagg, J., Noe, M. C., Wolf‐Gouveia, L. A., Reiter, L. A., Laird, E. R., Chang, S.-P., Danley, D. E., Downs, J. T., Elliott, N. C., Eskra, J. D., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.02.038 · Cited by 59
Synthesis of a Series of Stromelysin-Selective Thiadiazole Urea Matrix Metalloproteinase Inhibitors
Jacobsen, E. J., Mitchell, M. A., Hendges, S. K., Belonga, K. L., Skaletzky, L. L., Stelzer, L. S., Lindberg, T., Fritzen, E. L., Schostarez, H. J., O’Sullivan, T. J., et al. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9803222 · Cited by 58
Amin, E. A., & Welsh, W. J. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010236t · Cited by 54
Raitio, A., Tuomas, H., Kokkonen, N., Salo, T. A., Sorsa, T. A., Hanemaaijer, R., & Oikarinen, A. (2005) · Archives of Dermatological Research · doi:10.1007/s00403-005-0597-1 · Cited by 52
Potent and Selective Carboxylic Acid-Based Inhibitors of Matrix Metalloproteinases
Pikul, S., Ohler, N. E., Ciszewski, G., Laufersweiler, M. C., Almstead, N. G., De, B., Natchus, M. G., Hsieh, L. C., Janusz, M. J., Peng, S. X., et al. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm015531s · Cited by 52
Bertini, I., Calderone, V., Fragai, M., Luchinat, C., Mangani, S., & Terni, B. (2003) · Angewandte Chemie International Edition · doi:10.1002/anie.200350957 · Cited by 52
Acetylenic TACE inhibitors. Part 1. SAR of the acyclic sulfonamide hydroxamates
Levin, J. I., Chen, J. M., Cheung, K., Cole, D. C., Crago, C. F., Santos, E. D., Du, X., Khafizova, G., MacEwan, G., Niu, C., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00514-6 · Cited by 51
Welch, A. R., Holman, C. M., Huber, M., Brenner, M. C., Browner, M. F., & Wart, H. E. V. (1996) · Biochemistry · doi:10.1021/bi9601969 · Cited by 48
Hanessian, S., Moitessier, N., Gauchet, C., & Viau, M. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm010097f · Cited by 45
The discovery of anthranilic acid-based MMP inhibitors. Part 1: SAR of the 3-position
Levin, J. I., Du, M. T., DiJoseph, J. F., Killar, L. M., Sung, A., Walter, T., Sharr, M. A., Roth, C. E., Moy, F. J., Powers, R., et al. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00642-9 · Cited by 45
Venkatesan, A. M., Davis, J. M., Grosu, G. T., Baker, J., Zask, A., Levin, J. I., Ellingboe, J. W., Skotnicki, J. S., DiJoseph, J. F., Sung, A., et al. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm040086x · Cited by 43
QSAR of Chemical Polarizability and Nerve Toxicity. 2
Hansch, C. H., & Kurup, A. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci030289e · Cited by 37
Self-citationInhibition of MMP-1 and MMP-13 with phosphinic acids that exploit binding in the S2 pocket
Reiter, L. A., Rizzi, J. P., Pandit, J., Lasut, M. J., McGahee, S. M., Parikh, V. D., Blake, J. F., Danley, D. E., Laird, E. R., Lopez‐Anaya, A., et al. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00729-x · Cited by 36
A QSAR study on influenza neuraminidase inhibitors
Verma, R. P., & Hansch, C. H. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.09.016 · Cited by 36
Self-citationPhosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3
Reiter, L. A., Mitchell, P. G., Martinelli, G. J., Lopresti‐Morrow, L., Yocum, S. A., & Eskra, J. D. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00413-x · Cited by 34
Discovery of protease inhibitors using targeted libraries
Whittaker, M. A. (1998) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(98)80014-8 · Cited by 30
Wada, C. K. (2004) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026043388015 · Cited by 29
Synthesis and SAR of diazepine and thiazepine TACE and MMP inhibitors
Zask, A., Kaplan, J. A., Du, X., MacEwan, G., Sandanayaka, V. P., Eudy, N. H., Levin, J. I., Jin, G., Xu, J. Y., Cummons, T. A., et al. (2005) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2005.01.053 · Cited by 29
Fray, M. J., & DICKINSON, R. P. (2001) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(00)00720-4 · Cited by 28
Gupta, S. P., Maheswaran, V., Pande, V., & Kumar, D. (2003) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/1475636021000049735 · Cited by 28
Inhibition of Matrix Metalloproteinases: An examination of the S1′ pocket
Miller, A., Askew, M., Beckett, R. P., Bellamy, C. L., Bone, E. A., Coates, R. E., Davidson, A. H., Drummond, A. H., Huxley, P., Martin, F. M., et al. (1997) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(96)00602-6 · Cited by 27
Chemical–biological interactions in human
Verma, R. P., Kurup, A., Mekapati, S. B., & Hansch, C. H. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.10.064 · Cited by 26
Self-citationVerma, R. P., & Hansch, C. H. (2006) · Molecular Pharmaceutics · doi:10.1021/mp050110i · Cited by 22
Self-citationChapter 15. Matrix metalloproteinase inhibitors for treatment of cancer
Skiles, J. W., Monovich, L. G., & Jeng, A. Y. (2000) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(00)35016-3 · Cited by 21
Allosteric interactions and QSAR: On the role of ligand hydrophobicity
Hansch, C. H., Garg, R., Kurup, A., & Mekapati, S. B. (2003) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(03)00056-7 · Cited by 19
Self-citationChemical Toxicity on HeLa Cells
Verma, R. P., & Hansch, C. H. (2006) · Current Medicinal Chemistry · doi:10.2174/092986706775527910 · Cited by 18
Self-citationWetzel, M. K., Tibbitts, J. F., Rosenberg, G. A., & Cunningham, L. A. (2004) · APOPTOSIS · doi:10.1023/b:appt.0000038038.42809.e2 · Cited by 18
Simulation‐Based Predictions of Binding Affinities of Matrix Metalloproteinase Inhibitors
Khandelwal, A., Lukáčová, V., Kroll, D. M., Çömez, D., Raha, S., & Baláž, Š. (2004) · QSAR & Combinatorial Science · doi:10.1002/qsar.200430896 · Cited by 8
Cited by
Biochemical and Biological Attributes of Matrix Metalloproteinases
Cui, N., Hu, M., & Khalil, R. A. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.02.005 · Cited by 1,359
Vascular Endothelial Cell Biology: An Update
Krüger-Genge, A., Blocki, A., Franke, R.-P., & Jung, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184411 · Cited by 1,163
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
Molecular Mechanisms of Dermal Aging and Antiaging Approaches
Shin, J.-W., Kwon, S.-H., Choi, J.-Y., Na, J.-I., Huh, C.-H., Choi, H.-R., & Park, K.-C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092126 · Cited by 875
Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Jassam, Y. N., Izzy, S., Whalen, M., McGavern, D. B., & El Khoury, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.010 · Cited by 799
Metadata
- Authors
- Verma, R. P., & Hansch, C.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 15
- Issue
- 6
- Pages
- 2223-2268
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2103868159
- Cited by
- 783
- References
- 110
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.